Absence of high-risk Human Papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2169-2175

  Kusanagi, Yasuki ^a   Kojima, Atsumi ^a   Mikami, Yoshiki ^b   Kiyokawa, Takako ^c   Sudo, Tamotsu ^d   Yamaguchi, Satoshi ^d   Nishimura, Ryuichiro ^d  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d HYOGO CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

EID: 78149309466     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100323     Document Type: Article

References (49)

1. Smith HO, Tiffany MF, Qualls CR, Key CR: The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol 2000, 78:97-105
2. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E: Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005, 14:2191-2199
3. Sasieni P, Adams J: Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001, 357:1490-1493
4. Sherman ME, Wang SS, Carreon J, Devesa SS: Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival Cancer 2005, 103:1258-1264
5. Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT: Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007, 7:164
6. Bielska-Lasota M, Inghelmann R, van de Poll-Franse L, Capocaccia R: Trends in cervical cancer survival in Europe, 1983-1994: a population-based study. Gynecol Oncol 2007, 105:609-619
7. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ: Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer 2003, 89:834-839
8. Herzog TJ, Monk BJ: Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol 2007, 197:566-571
9. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E: The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001, 37:246-250
10. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006, 98:303-315
11. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73
12. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C: Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000, 157:1055-1062
13. Park KJ, Lamb C, Oliva E, Soslow RA, Kiyokawa T: Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Mod Pathol 2008, 21:217A
14. Ferguson AW, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1998, 11:11-18
15. Toki T, Zhai YL, Park JS, Fujii S: Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix. Int J Gynecol Pathol 1999, 18:215-219
16. Xu JY, Hashi A, Kondo T, Yuminamochi T, Nara M, Hashi K, Murata S, Katoh R, Hoshi K: Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2005, 24:296-302
17. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE: Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989, 13:717-729
18. Wells M, Ostör AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, Goodman AK, Sankaranarayanan R, Hanselaar AG, Albores-Saavedra J: Epithelial Tumours. Tumours of the Uterine Cervix. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Edited by Tavassoli FA, Stratton MR. Lyon, IARC Press 2003, 262-279
19. Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira J, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H: Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum.' Mod Pathol 2004, 17:962-972
20. Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, Nishimura R: Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 2007, 31:664-672
21. Mikami Y, Hata S, Melamed J, Fujiwara K, Manabe T: Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001, 39:364-372 (Pubitemid 32990087)
22. Kawauchi S, Kusuda T, Liu XP, Suehiro Y, Kaku T, Mikami Y, Takeshita M, Nakao M, Chochi Y, Sasaki K: Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol 2008, 32:1807-1815
23. Kawakami F, Mikami Y, Kojima A, Ito M, Nishimura R, Manabe T: Diagnostic reproducibility in gastric-type mucinous adenocarcinoma of the uterine cervix: validation of novel diagnostic criteria. Histopathology 2010, 56:551-553
24. Young RH, Clement PB: Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002, 41:185-207
25. Nishiwaki M, Yamamoto T, Tone S, Murai T, Ohkawara T, Matsunami T, Koizumi M, Takagi Y, Yamaguchi J, Kondo N, Nishihira J, Horikawa T, Yoshiki T: Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications. J Clin Microbiol 2008, 46:1161-1168
26. Minaguchi T, Yoshikawa H, Nakagawa S, Yasugi T, Yano T, Iwase H, Mizutani K, Shiromizu K, Ohmi K, Watanabe Y, Noda K, Nishiu M, Nakamura Y, Taketani Y: Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix. Cancer Lett 2004, 210:57-62
27. Nagai Y, Maehama T, Asato T, Kanazawa K: Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa. Japan Am J Clin Oncol 2001, 24:160-166
28. Sano T, Shimooka H, Weixa P, Segawa A, Jian Z, Motegi A, Nakayama H, Oyama T, Nakajima T: Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int 2004, 54:743-750
29. Ueda Y, Miyatake T, Okazawa M, Kimura T, Miyake T, Fujiwara K, Yoshino K, Nakashima R, Fujita M, Enomoto T: Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix. Am J Clin Pathol 2008, 130:389-400
30. Yoshida T, Sano T, Oyama T, Kanuma T, Fukuda T: Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch 2009, 455:253-259
31. Milde-Langosch K, Schreiber C, Becker G, Loning T, Stegner HE: Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 1993, 24:590-594
32. Tenti P, Romagnoli S, Silini E, Pellegata NS, Zappatore R, Spinillo A, Zara C, Ranzani GN, Carnevali L: Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix. Int J Cancer 1995, 64:9-13
33. Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL: Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol 1994, 84:404-408
34. Kuragaki C, Enomoto T, Ueno Y, Sun H, Fujita M, Nakashima R, Ueda Y, Wada H, Murata Y, Toki T, Konishi I, Fujii S: Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 2003, 83:35-45
35. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ: World Health Organization: Histological Typing of Female Genital Tract Tumours. Berlin, Springer-Verlag, 1994, pp 39-54
36. An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, Suh KS, Seo EJ, Sung SH, Sohn JH, Yoon HK, Chang ED, Cho HI, Han JY, Hong SR, Ahn GH: Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005, 18:528-534
37. Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K: Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 1996, 318 (Pt 2):409-416
38. Ishii K, Hosaka N, Toki T, Momose M, Hidaka E, Tsuchiya S, Katsuyama T: A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998, 432:315-322
39. Dong SM, Kim HS, Rha SH, Sidransky D: Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001, 7:1982-1986
40. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG: In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999, 96:12754-12759
41. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF: Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001, 7:584-589
42. Park JS, Dong SM, Kim HS, Lee JY, Um SJ, Park IS, Kim SJ, Namkoong SE: Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 1999, 136:101-108
43. Houghton OP, Jamison J, Wilson R, Carson J, McCluggage WG: Unusual Morphologic types of cervical adenocarcinoma are not associated with human papillomavirus infection. Mod Pathol 2010, 23 (Suppl 1):247A
44. Miura S, Matsumoto K, Oki A, Satoh T, Tsunoda H, Yasugi T, Taketani Y, Yoshikawa H: Do we need a different strategy for HPV screening and vaccination in East Asia? Int J Cancer 2006, 119:2713-2715
45. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ: Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004, 111:278-285
46. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H: Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997, 65:23-29
47. Parker MF, Arroyo GF, Geradts J, Sabichi AL, Park RC, Taylor RR, Birrer MJ: Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol 1997, 64:242-251
48. Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K: Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: p53 status has a strong impact on prognosis. Int J Radiat Oncol Biol Phys 2004, 60:231-236
49. Ichimura T, Koizumi T, Tateiwa H, Yamaguchi S, Takemori M, Hasegawa K, Nishimura R: Immunohistochemical expression of gastric mucin and p53 in minimal deviation adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2001, 20:220-226